Financials
- Market Capitalization 428.46 M
- Employee 73
- Founded 2005
- CEO Jason Okazaki
- Website www.assemblybio.com
- Headquarter Delaware, United States
- FIGI BBG000R62Q06
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-61.84
Fiyat/satışlar oranı
5.27
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3016 | EVMN Evommune, Inc. Common Stock | 12.11 USD | -8.33% | -10.76% | -39.51% | -30.08% | 436.18 M USD | ||
| 3022 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.92 USD | -3.45% | -5.54% | -1.51% | +64.71% | 433.42 M USD | ||
| 3046 | TENX Tenax Therapeutics, Inc. - Common Stock | 15.98 USD | -8.95% | -1.36% | +37.17% | +111.66% | 423.87 M USD | ||
| 3053 | AGMB AgomAb Therapeutics NV - ADRs representing one | 12.31 USD | -5.89% | -9.68% | +24.47% | -16.26% | 420.60 M USD |